Рак шейки матки. Причина и профилактика
https://doi.org/10.17650/1994-4098-2010-0-4-58-63
Аннотация
Статья затрагивает актуальные вопросы онкологии – роль табака в возникновении и развитии плоскоклеточного рака шейки матки. Здесь собраны и представлены материалы, доказывающие влияние табакокурения на течение заболевания, на результаты различных видов лечения и прогноз. Также показано значение пассивного курения в прогрессии плоскоклеточного рака и рассмотрены возможные пути профилактики.
Ключевые слова
Об авторах
Ф. М. Мейскенс
Онкологический центр семьи Чао, Калифорнийский университет, США
Соединённые Штаты Америки
Соединённые Штаты Америки
Д. Пател
Онкологический центр семьи Чао, Калифорнийский университет, США
Соединённые Штаты Америки
Соединённые Штаты Америки
Список литературы
1. Ferlay J., Shin H., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12):2893-917.
2. Aleksandrova I.N, Lyshchev A.A, Safronnikova N.R. et al. Papillomavirus infection in healthy women from St.Petersburg. Vopr Onkol 2000; 46(2):175-9.
3. Belinson J., Qiao Y.L., Pretorius R. et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. GynecolOncol 2001;83(2):439-44.Erratum in: Gynecol Oncol 2002 ;84 (2):355.
4. Blumenthal P.D., Gaffikin L., Chirenje Z.M. et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72 (1):47-53.
5. Clavel C., Masure M., Bory J.P. et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84(12):1616-23.
6. Lazcano-Ponce E., Herrero R., Muñoz N. et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. IntJCancer 2001;91(3):412-20.
7. Matos E., Loria D., Amestoy G.M. et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transmis Dis 2003;30(8):593-9.
8. Sellors J.W., Maony J.B., Kaczorowski J. et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW)Group.CMAJ 2000;163(5):503-8.
9. Schiffman M., Castle P.E. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127 (8):930-4.
10. Wiley D.J., Douglas J., Beutner K. et al. External genital warts: diagnosis, treatment, andprevention. ClinInfectDis 2002;35(suppl 2):210-24.
11. Muñoz N., Bosch F.X., de Sanjosé S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348 (6):518-27.
12. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89(1):101-5.
13. Jansen K.U., Shaw A.R. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 2004;55:319-31.
14. Clifford G.M., Smith J.S., Plummer M. et al.Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88 (1):63-73.
15. Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999; 189 (1):1-3.
16. Baay M.F., Verhoeven V., Avonts D., Vermorken J.B. Risk factors for cervical cancer development:whatdowomenthink?Sex Health.2004;1(3):145-9.
17. Castle P.E., Wacholder S., Lorincz A.T. et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus- infected women. J Natl Cancer Inst 2002;94 (18):1406-14.
18. Goodman A., Wilbur D.C. Case 32-2003: A 37 year-old woman with atypical squamous cells on a papanicolaou smear. N Engl J Med.. 2003;349 (16):1555-64.
19. Bory J.P., Cucherousset J., Lorenzato M. et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smearsatriskfordevelopinghighgradecervical lesions: a longitudinal study of 3,091 women. Int J Cancer 2002;102 (5):519-25.
20. Ho G.Y., Bierman R., Beardsley L. et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338 (7):423-8.
21. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J. et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001 ;358 (9295):1782-3.
22. Koutsky L.A., Ault K.A., Wheeler C.M. et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645-51.
23. HarperD.M.,FrancoE.L.,WheelerC. et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004 ;364(9447):1757-65.
24. McCann M.F., Irwin D.E., Walton L.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125-9.
25. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118(6):1481-95.
26. Roteli-Martins C.M., Panetta K., Alves 2 Vam Siqueira S.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125-9.
27. Ho G.Y., Kadish A.S., Burk R.D. et al. HPV16andcigarettesmokingasriskfactorsfor high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998 ;78(3):281-5.
28. McIntyre-Seltman K., Castle P.E., Guido R. et al.ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14(5):1165-70.
29. Szarewski A., Jarvis M.J., Sasieni P. et al. Effect of smoking cessation on cervical lesion size. Lancet.1996 ;348 (9028):682-3.
30. Kucera H., Enzelsberger H., Eppel W., Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer. .1987 ;60(1):1-4.
31. Fyles A., Voduc D., Syed A. et al. The effect of smoking on tumour oxygenation and treatment outcome in cervical cancer. Clin Oncol (R Coll Radiol) 2002;14(6):442-6.
32. Waggoner S.E., Darcy K.M., Fuhrman B. et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study.
33. Gynecol Oncol. In press 2006.
34. Coker A.L., Bond S.M., Williams A. et al. Active and passive smoking, high-risk human papillomaviruses and cervical neoplasia. Cancer DetectPrev2002;26(2):121-8.
35. Hellberg D., Nilsson S., Haley N.J. et al. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 1988;158:910-3.
36. Jones C.J., Schiffman M.H., Kurman R. et al. Elevated nicotine levels in cervical lavages from passive smokers. Am J Public Health 1991;81:378-9.
37. Kulikauskas V., Blaustein D., Ablin R.J. Cigarette smoking and its possible effects on sperm. Fertil Steril 1985;44:526-8.
Рецензия
Для цитирования:
Мейскенс Ф.М., Пател Д. Рак шейки матки. Причина и профилактика. Опухоли женской репродуктивной системы. 2010;(4):58-63. https://doi.org/10.17650/1994-4098-2010-0-4-58-63
For citation:
Meyskens F.M., Patel D. Cancer of the cervix uteri. Causes and prevention. Tumors of female reproductive system. 2010;(4):58-63. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-4-58-63
Просмотров: 423
Послать статью по эл. почте 